Event/Clinical trial
Scheduled
Expected entry into Phase 3 after consultation with FDA
Actors and targets
Source
추후 FDA와의 협의를 통해 빠르게 임상 3상에 진입할 것으로 전망
Related events
Same kind only, ranked by embedding similarity to this record.
추후 FDA와의 협의를 통해 빠르게 임상 3상에 진입할 것으로 전망
Same kind only, ranked by embedding similarity to this record.